Akari Therapeutics Plc (AKTX)
10.25
-0.12
(-1.16%)
USD |
NASDAQ |
Sep 02, 16:00
10.25
0.00 (0.00%)
After-Hours: 19:41
Akari Therapeutics Research and Development Expense (TTM) : 4.869M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.869M |
| March 31, 2026 | 3.464M |
| December 31, 2025 | 2.820M |
| September 30, 2025 | 2.971M |
| June 30, 2025 | 2.867M |
| March 31, 2025 | 5.505M |
| December 31, 2024 | 6.971M |
| September 30, 2024 | 7.467M |
| June 30, 2024 | 10.18M |
| March 31, 2024 | 9.001M |
| March 31, 2023 | 10.57M |
| June 30, 2022 | 11.48M |
| March 31, 2022 | 12.99M |
| December 31, 2021 | 17.91M |
| September 30, 2021 | 18.72M |
| June 30, 2021 | 17.87M |
| March 31, 2021 | 19.54M |
| December 31, 2020 | 17.94M |
| September 30, 2020 | 19.12M |
| June 30, 2020 | 22.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.56M |
| December 31, 2019 | 16.65M |
| September 30, 2019 | 13.18M |
| June 30, 2019 | 11.81M |
| March 31, 2019 | 13.34M |
| December 31, 2018 | 11.80M |
| September 30, 2018 | 16.55M |
| June 30, 2018 | 19.63M |
| March 31, 2018 | 18.29M |
| December 31, 2017 | 23.29M |
| September 30, 2017 | 22.18M |
| June 30, 2017 | 20.17M |
| March 31, 2017 | 21.83M |
| December 31, 2016 | 17.25M |
| September 30, 2016 | 13.15M |
| June 30, 2016 | 10.10M |
| March 31, 2016 | 4.792M |
| December 31, 2015 | 4.824M |
| September 30, 2015 | 3.261M |
| June 30, 2015 | 2.047M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| DBV Technologies SA | 117.13M |
| Cellectis SA | 82.95M |
| argenx SE | 1.640B |
| Autolus Therapeutics Plc | 112.42M |
| Evaxion AS | 10.27M |